measles-rubella vaccine

BIOLOGICAL3 trials

Sponsors

PATH, Sichuan Center for Disease Control and Prevention, Nicole Stoffel

Conditions

Iron DeficienciesMeasles Antibody SeroconversionRotavirusRotavirus Geometric Mean Titer (GMT)Rotavirus Immunoglobulin A (IgA) SeropositivityRubella Antibody Seroconversion

Phase 4

Coadministration of Measles-rubella and Rotavirus Vaccines

CompletedNCT01700621

PATHMeasles Antibody Seroconversion, Rotavirus Geometric Mean Titer (GMT), Rotavirus Immunoglobulin A (IgA) Seropositivity +1

Start: 2013-01-31End: 2013-09-30Updated: 2019-03-13

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Sichuan Center for Disease Control and PreventionRotavirus

Start: 2013-12-31End: 2014-08-31Target: 2800Updated: 2014-06-03

Unknown Phase

The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency

Not yet recruitingNCT06816524

Nicole StoffelIron Deficiencies

Start: 2026-01-05End: 2028-04-30Target: 324Updated: 2025-12-26

Related Papers

Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial

The Journal of Infectious Diseases2016-01-2746 citations